News | News By Subject | News by Disease News By Date | Search News

Alzheimer's Disease News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Johnson & Johnson Strikes $509 Million Alzheimer's Deal With AC Immune SA     1/12/2015
Actavis, Adamas Pharmaceuticals Win FDA Approval for Alzheimer's Drug Namzaric     1/5/2015
Roche Suffers A Double Blow As Breast Cancer, Alzheimer’s Drug Studies Fail; Pulls Plug On ALZ's Drug Development     12/23/2014
Actavis Ordered To Keep Selling Alzheimer's Pill     12/12/2014
Investors Cheer As Biogen Idec's BIIB037 Skips To Phase 3 For Alzheimer's     12/4/2014
Is New Alzheimer’s Drug the Stabilizing Force Biogen Idec Needs?     12/3/2014
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
AstraZeneca PLC And Eli Lilly Move Alzheimer's Drug Into Big Trial     12/1/2014
Best Value In Biotech? Actavis, Says UBS     11/17/2014
Astellas Pharma Inc., CoMentis, Inc. Terminate Alzheimer's Agreement     10/17/2014
Actavis Will Keep Selling Alzheimer's Drug In U.S. For 60 Days     9/26/2014
Google Inc.-Backed Calico Announces Plan To Combat ALS, Parkinson's     9/16/2014
AVANIR Pharmaceuticals Rockets As Lead Drug Succeeds In Reducing Alzheimer's Related Agitation; Stock Up 63.20% At 10:19AM ET On Monday     9/16/2014
Roche Alzheimer's Drug Crenezumab Fails Main Goals In Phase 2 Study     7/17/2014
Targacept, Inc. Stops Alzheimer's Drug Trial After It Fails Phase 2b Trial     7/16/2014

Featured Stories
Diet Affects Brain Iron Levels Differently In Men And Women, University at Buffalo Study Shows     1/27/2015
Common Mood Changes May Signal Early Alzheimer’s, Washington University School of Medicine Study     1/15/2015
Natural Product Found In Turmeric May Fight Alzheimer’s, Vanderbilt University Reveals     1/14/2015
Nasal Spray May Cure Dementia And Alzheimer's, Wake Forest University Baptist Medical Center Study     1/13/2015
Top Medical Advances Of 2014     1/5/2015
Lost Memories May Be Restored, New University of California, Los Angeles (UCLA) Study Indicates     12/24/2014
The Dementia That Is Not Alzheimer’s Disease     12/24/2014
Now Researchers Can See How Unfolded Proteins Move In The Cell, University of Illinois Reveals     12/11/2014
Imaging Shows Brain Connection Breakdown In Early Alzheimer's Disease, Duke University Medical Center Study     12/2/2014
Regular Coffee Consumption Could Keep Alzheimer's At Bay, Institute For Scientific Information On Coffee Study     12/1/2014
Brain Network May Be Vulnerable To Alzheimer’s And Schizophrenia, Oxford University Study     11/26/2014
Stanford University Biologists Explore Link Between Memory Deficit And Misfiring Circadian Clock     11/24/2014
Complex Jobs "May Protect Memory," Heriot-Watt University Study     11/20/2014
Does "Brain Training" Work? University of Sydney Study     11/20/2014
Dementia Study Questions Advice On Taking Supplements, Wageningen University Reveals     11/14/2014

More News
Amarantus BioSciences, Inc. Forms Alzheimer's Disease Diagnostics Scientific Advisory Board     1/22/2015
PsychoGenics Inc. Obtains A License To The McGill Universityl-R-Thy1-APP Rat Model Of Alzheimer’s Disease     1/21/2015
TauRx Therapeutics Release: First Evidence Of Potential Efficacy Of Tau Aggregation Inhibitor Therapy In Alzheimer's Disease     1/20/2015
Wake Forest University Release: Nasal Spray With Insulin Equivalent Shows Promise As Treatment For Adults With Mild Cognitive Impairment, Alzheimer's Dementia     1/19/2015
Amarantus BioSciences, Inc. Announces Positive Data From 140 Subject LP-002 Clinical Study Of Lympro Test® Confirming Statistically Significant Markers For Alzheimer's     1/15/2015
Amarantus BioSciences, Inc. Announces Exclusive Option Agreement With Georgetown University To License Patent Rights For Blood Based Biomarkers For Alzheimer's Disease     1/15/2015
National Research Council of Canada And KalGene Pharmaceuticals Announce License Agreement For The Development Of Novel Alzheimer's Therapeutics     1/14/2015
Neurotrope Forms Clinical Advisory Board To Support Alzheimer's Disease Program     1/14/2015
Anavex Life Sciences Corp. (AVXL.OB) Doses First Alzheimer's Patient In Phase 2a Trial Of ANAVEX 2-73 And ANAVEX PLUS     1/12/2015
GliaCure Completes Phase 1a Clinical Trial In Alzheimer's Disease     1/6/2015
Alzheon Announces Patent Allowance In Europe For ALZ-801 In Development For Alzheimer’s Disease     1/5/2015
Alzheimer's Association Mourns Death Of Founding President And Honorary Chair Jerome H. Stone     1/2/2015
Amarantus BioSciences, Inc. To Present LP-002 Data For Alzheimer's Blood Diagnostic Lympro Test® At Biotech Showcase 2015 Conference On January 14, 2015     12/29/2014
Actavis (ACT) and Adamas Pharmaceuticals (ADMS) Announce FDA Approval of Namzaric™, a Fixed-Dose Combination of Memantine Extended-Release and Donepezil Hydrochloride     12/24/2014
Amarantus BioSciences, Inc. Commences Launch Of Proprietary Alzheimer's Blood Diagnostic Lympro Test® To Pharmaceutical Industry For Use In Clinical Trials     12/22/2014

//-->